For new investors, I would recommend buying ACCL before the close of its March quarter.

FORBES: Top Nanotech Buys For 2005

The accounting switch and the confusion surrounding it has had more of an effect on ACCL's stock price than anything else.

FORBES: Top Nanotech Buys For 2005

While this did not affect ACCL's cash flows this year, it significantly reduced revenue recognition over the past 12 months--confusing investors trying to gauge the health of the company's business.

FORBES: Top Nanotech Buys For 2005

This means the subscription revenue that had been building as backlog for the past four quarters will finally begin to hit the income statement and that ACCL will likely crush year-over-year comparisons in the current quarter (ending March 31, 2005).

FORBES: Top Nanotech Buys For 2005